TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

defer us trials until cashflow, page-39

  1. TDA
    11,411 Posts.
    lightbulb Created with Sketch. 137
    clock Created with Sketch.
    05/12/12
    19:45
    Post #: 11151896
    "FDA approval is biased"

    Is that as opposed to the MHRA or the EMA:)


    TIS Price at posting: 30.0¢ Sentiment: LT Buy Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Outstanding metallurgical results significantly de-risk Mandilla gold project
right-arrow Created with Sketch.
NEWS RDN: HotCopper's most discussed stock
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.